CompletedNCT01135849

B-Receptor Signaling in Cardiomyopathy

Studying Adenocarcinoma of the anal canal

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Daniel Bernstein
Principal Investigator: Daniel Bernstein
Stanford University
Enrollment: 99 enrolled
Eligibility: 40 years · All sexes
Timeline: 2008 – 2010

Study locations (1)

Stanford University School of Medicine, Stanford, California, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01135849 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the anal canal

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center

See all trials for Adenocarcinoma of the anal canal →

← Back to all trials